DLV and another v DLX and others [2025] SGHC 29

Sushant Shukla

Case Details

Citation: [2025] SGHC 29
Court: General Division of the High Court of the Republic of Singapore
Decision Date: 21 February 2025
Coram: Kristy Tan JC
Case Number: Originating Application No 1033 of 2024
Hearing Date(s): 17 January 2025
Claimants / Plaintiffs: DLV (1st Promoter); DLW (2nd Promoter)
Respondents / Defendants: DLX; DLY; DLZ; DMA (collectively, the Investors)
Counsel for Claimants: Abraham Vergis SC, Ngo Wei Shing, and Liu Enning (Providence Law Asia LLC)
Counsel for Respondents: Thio Shen Yi SC, Nguyen Vu Lan, Chia Wan Lu, and Nicole Sim (TSMP Law Corporation)
Practice Areas: International Arbitration; Setting Aside of Arbitral Awards; Natural Justice; Breach of Fair Hearing Rule
Statutory Basis: Section 24(b) of the International Arbitration Act 1994 (2020 Rev Ed)

The decision in DLV and another v DLX and others [2025] SGHC 29 provides a sophisticated examination of the "fair hearing rule" within the context of Singapore’s pro-arbitration framework. The case centers on an application by two Promoters of an Indian-incorporated company to set aside an arbitral award dated 5 July 2024. The Promoters alleged that the arbitral tribunal (the "Tribunal") committed two distinct breaches of natural justice under s 24(b) of the International Arbitration Act 1994: first, by failing to consider a "Waiver Defence" regarding the Investors' exit rights; and second, by failing to address a "Buy-back Defence" concerning the legality of share repurchases under the Indian Companies Act 2013.

The High Court, per Kristy Tan JC, delivered a nuanced judgment that distinguishes between a procedural error and a fatal breach of natural justice. The Court found that while the Tribunal had indeed failed to apply its mind to the Waiver Defence—constituting a breach of the fair hearing rule—this breach did not warrant setting aside the award because it caused no actual prejudice. The Court determined that the Waiver Defence was legally and factually unsustainable in light of the express "No Waiver" provisions in the underlying Share Acquisition & Shareholders’ Agreement (the "SASHA"). Consequently, the outcome of the arbitration would have remained unchanged even if the Tribunal had properly considered the defense.

Regarding the Buy-back Defence, the Court found no breach of natural justice. It held that the Tribunal had sufficiently engaged with the core of the Promoters' arguments, even if it did not explicitly reference every statutory provision cited by the parties. The judgment reaffirms the high threshold for setting aside awards in Singapore, emphasizing that a "clear and virtually inescapable inference" of a failure to consider an issue is required. Furthermore, it highlights the critical role of the "prejudice" requirement, serving as a filter to ensure that only those procedural lapses that truly affect the justice of the case result in the annulment of an award.

This case serves as a vital reminder for practitioners that the Singapore courts will not act as a court of appeal on the merits of an arbitral decision. Even where a tribunal is found to have "missed" a pleaded defense, the court will conduct a rigorous de novo assessment of that defense to determine if its omission had any material impact. The decision underscores the robustness of "No Waiver" clauses and the importance of clear, structured pleading in complex international arbitrations.

Timeline of Events

10 October 2014: The Company (incorporated in India), the Promoters (DLV and DLW), the Investors (DLX, DLY, DLZ, and DMA), and two other parties execute the Share Acquisition & Shareholders’ Agreement (SASHA).
31 March 2016: Certain Investors issue the first set of Secondary Sale Initiation Notices under the SASHA framework.
1 April 2016: Additional Secondary Sale Initiation Notices are issued by the remaining Investors.
26 April 2016: A date relevant to the subsequent interactions between the Promoters and Investors regarding the exit strategy and potential third-party buyers.
18 September 2020: A significant date in the factual matrix regarding the ongoing dispute over the exit rights and the valuation of the Company.
5 January 2021: Further correspondence or events occurring between the parties as the dispute over the failure to facilitate a Secondary Sale matured.
26 March 2021: A milestone in the parties' negotiations or procedural steps leading toward the eventual breach notices.
11 April 2022: The Investors issue formal notices of material breach to the Promoters, alleging failure to facilitate the Secondary Sale as required by the SASHA.
21 April 2022: Subsequent notices or responses following the initial breach notices.
30 April 2022: The deadline or event marking the escalation of the dispute toward formal arbitration proceedings.
28 November 2022: Commencement of the arbitration proceedings by the Investors against the Promoters.
21 March 2023: A procedural milestone within the arbitration, potentially involving the filing of the Statement of Claim.
23 August 2023: Further evidentiary or procedural step in the arbitral process, possibly related to witness statements.
19 October 2023: A date relevant to the submissions or hearings before the Tribunal.
10 November 2023: Continued proceedings in the arbitration, including the filing of the Statement of Defence.
22 November 2023: A date marking the conclusion of certain phases of the arbitral hearing or the closing of the record.
19 January 2024: A date relevant to the final submissions or post-hearing briefs.
9 February 2024: A further procedural date in the lead-up to the final award.
5 July 2024: The Tribunal issues the Final Award (the "Award") in favor of the Investors, finding the Promoters in breach.
15 October 2024: The Promoters file Originating Application No 1033 of 2024 in the High Court of Singapore to set aside the Award.
10 January 2025: Final submissions or closing of the record in the set-aside application.
17 January 2025: Substantive hearing of OA 1033 before Kristy Tan JC.
21 February 2025: The High Court delivers its judgment dismissing the application.

What Were the Facts of This Case?

The dispute arose from a private equity investment in an Indian company founded by the Promoters, DLV and DLW. The Investors, comprising four private equity funds (DLX, DLY, DLZ, and DMA), provided capital to the Company under the terms of the Share Acquisition & Shareholders’ Agreement (SASHA) dated 10 October 2014. The SASHA was governed by Indian law and contained a comprehensive suite of "Exit Rights" designed to ensure that the Investors could liquidate their holdings and realize their investment within a specific timeframe. These rights were primarily structured across Clause 19 (Secondary Sale), Clause 24.4(c) (Material Breach), and Clause 24.6 (Consequences of Breach).

Under Clause 19.1 of the SASHA, if the Investors had not achieved an exit through an Initial Public Offering (IPO) or a Strategic Sale by a certain date, they were entitled to initiate a "Secondary Sale." This mechanism required the Promoters and the Company to use their best efforts to find a third-party purchaser for the Investors' shares at a price that would provide a specified minimum return. The SASHA imposed an absolute obligation on the Promoters to facilitate this exit. If no such purchaser was found within a set period, the Investors could trigger further rights, including a potential buy-back of shares by the Company or a mandatory sale of the Promoters' own shares to satisfy the Investors' exit requirements.

In March and April 2016, the Investors issued Secondary Sale Initiation Notices. However, no Secondary Sale was successfully concluded. Between 2016 and 2022, the Company underwent various corporate developments, including subsequent rounds of financing and changes in management. The Promoters contended that during this six-year period, the Investors had effectively abandoned the 2016 notices. They pointed to the Investors' continued participation in board meetings, their approval of financial statements, and their failure to pursue the Secondary Sale rights for several years as evidence that the Investors had waived their rights or were estopped from asserting a breach.

The Investors, conversely, maintained that their rights remained intact and that the Promoters had failed in their absolute obligation to facilitate the exit. They argued that the delay was a result of the Promoters' own failure to find a buyer and that the "No Waiver" provisions in the SASHA protected them from any loss of rights due to inaction. In April 2022, the Investors issued notices of material breach, and when the Promoters failed to remedy the situation, they commenced arbitration in November 2022. The Investors sought damages equivalent to the value they would have received had the Secondary Sale been properly executed in 2016.

In the arbitration, the Promoters raised several defenses, two of which became the focal point of the subsequent set-aside application. The first was the "Waiver Defence," where they argued that the Investors' conduct between 2016 and 2022 constituted a waiver of the right to insist on the Secondary Sale. The second was the "Buy-back Defence," which had two limbs: (a) the "Buy-back Limb," arguing that the SASHA limited the Investors' remedy to a buy-back of shares; and (b) the "Unenforceability Limb," arguing that such a buy-back was legally prohibited under section 67(1) of the Indian Companies Act 2013 because the Company could not legally purchase its own shares in its financial state.

The Tribunal issued its Award on 5 July 2024, finding the Promoters liable for breach of contract and ordering them to pay substantial damages. The Tribunal concluded that the obligation to facilitate the Secondary Sale was an absolute one and that the Promoters had failed to discharge it. However, the Award's treatment of the Waiver Defence was notably sparse, and it did not explicitly reference the "Unenforceability Limb" of the Buy-back Defence, leading the Promoters to seek recourse in the High Court of Singapore.

What Were the Key Legal Issues?

The primary legal issue was whether the arbitral award should be set aside under s 24(b) of the International Arbitration Act 1994 on the grounds of a breach of natural justice. This broad inquiry was subdivided into three critical questions:

The Waiver Defence Issue: Did the Tribunal breach the fair hearing rule by failing to apply its mind to the Promoters’ Waiver Defence? This required the Court to determine if the Tribunal's silence on the merits of the defense, despite acknowledging it in the summary of parties' positions, constituted a failure to consider an essential issue.
The Buy-back Defence Issue: Did the Tribunal breach the fair hearing rule by failing to consider the "Unenforceability Limb" of the Buy-back Defence? The Promoters argued that the Tribunal ignored their submission that the exit provisions were unenforceable under section 67(1) of the Indian Companies Act 2013.
The Prejudice Requirement: If a breach of natural justice occurred, did it cause "actual or real prejudice" to the Promoters? This involved a de novo assessment of whether the omitted defenses had any reasonable prospect of altering the Tribunal's final decision.

The framing of these issues required the Court to balance the principle of minimal curial intervention against the fundamental right of a party to have its case heard. The Promoters argued that the failure to address a "core" defense is a fundamental error that strikes at the heart of the arbitral process. The Investors contended that the Tribunal had implicitly rejected the defenses or that they were so meritless that their omission was immaterial to the final outcome.

How Did the Court Analyse the Issues?

The Court began its analysis by reiterating the established legal framework for setting aside an award for breach of natural justice. Citing AKN and another v ALC and others [2015] 3 SLR 488 ("AKN") and ASG v ASH [2016] 5 SLR 54 ("ASG"), the Court noted that a party must establish: (a) which rule of natural justice was breached; (b) how it was breached; (c) in what way the breach was connected to the making of the award; and (d) how the breach prejudiced the party’s rights. The Court emphasized that the failure to consider an essential issue must be a "clear and virtually inescapable inference" from the award.

Analysis of the Waiver Defence

The Court found that the Tribunal had indeed breached the fair hearing rule regarding the Waiver Defence. The Promoters had pleaded this defense extensively in their Statement of Defence at paragraph 12725, arguing that the Investors had waived or were estopped from asserting their rights to a Secondary Sale. While the Tribunal summarized the Promoters' position on waiver in the "Parties' Positions" section of the Award, it failed to make any findings on it in the "Findings" section. The Court observed:

"The Tribunal’s failure to consider the Waiver Defence is a clear and virtually inescapable inference from the Award... The Tribunal did not deal with the Waiver Defence at all in its findings." (at [31])

The Court rejected the Investors' argument that the Tribunal had implicitly rejected the Waiver Defence. It noted that the Tribunal had structured its findings by addressing specific "Issues for Determination," but the Waiver Defence did not fit into any of the sub-issues the Tribunal actually analyzed. Unlike cases where a tribunal's rejection of a primary claim logically disposes of a secondary defense, the Waiver Defence here was an independent "confession and avoidance" plea that required separate consideration. The Court held that the Tribunal's failure to address it was a procedural error.

Analysis of the Buy-back Defence

In contrast, the Court found no breach of natural justice regarding the Buy-back Defence. The Promoters argued the Tribunal ignored the "Unenforceability Limb"—the argument that a buy-back was legally prohibited under section 67(1) of the Indian Companies Act 2013. However, the Court pointed to specific paragraphs in the Award where the Tribunal discussed the "Buy-back Limb" and the "Secondary Sale Limb." The Tribunal had concluded that the Promoters' obligations were not contingent on the legality of a buy-back. The Court held:

"The Tribunal’s award of reliefs ultimately included orders that the Company and the Promoters shall... facilitate the Secondary Sale... These matters show that the Unenforceability Limb was on the Tribunal’s mind." (at [97]-[98])

The Court emphasized that a tribunal is not required to "explicitly deal with every point made by the parties," citing ASG at [59(e)]. The Tribunal had engaged with the "essential issue" of whether the exit rights were enforceable, and its failure to mention section 67(1) specifically did not mean the argument was ignored. The Tribunal had simply preferred an interpretation of the SASHA that made the statutory restriction irrelevant to the breach of the Secondary Sale obligation.

The Critical Requirement of Prejudice

The most significant part of the Court's analysis concerned the requirement of prejudice. Under Singapore law, a breach of natural justice only leads to setting aside if it caused "actual or real prejudice." The Court conducted a de novo review of the Waiver Defence to see if it had any merit. It found the defense was "doomed to fail" for two primary reasons:

The "No Waiver" Clause: Clause 29.5 of the SASHA explicitly stated that no failure or delay in exercising a right would operate as a waiver. The Court found that this clause was "clear and broad," covering exactly the type of conduct the Promoters relied upon (i.e., the Investors' delay in enforcing the 2016 notices).
Factual Insufficiency: The Promoters failed to point to any "clear and unequivocal" representation by the Investors that they were abandoning their rights. Mere participation in the Company's affairs did not constitute a waiver of the right to an exit.

The Court applied the test from BZW and another v BZV [2022] 1 SLR 1080 ("BZW"), noting that an award will not be set aside if the breach had no impact on the outcome. Because the Waiver Defence was legally hopeless due to the SASHA's own terms, the Tribunal's failure to consider it did not change the result of the arbitration. Therefore, there was no prejudice, and the Award could not be set aside.

What Was the Outcome?

The High Court dismissed the Promoters' application in its entirety. The operative order of the Court was definitive:

"OA 1033 is dismissed." (at [103])

The dismissal of the Originating Application means that the arbitral award dated 5 July 2024 remains valid and enforceable. The Promoters are bound by the Tribunal's orders to pay damages to the Investors for the breach of the SASHA's exit provisions. The Court's decision to maintain the award, despite finding a technical breach of the fair hearing rule, reinforces the principle that the Singapore courts will not interfere with an award unless a procedural error has a material impact on the justice of the case.

Regarding the costs of the application, the Court did not make an immediate order but provided a mechanism for the parties to resolve the issue. The Court directed that:

"Unless the parties agree on costs, they should file their written submissions on costs, limited to three pages, within two weeks from the date of this judgment." (at [104])

The deadline for these submissions was set for 7 March 2025. This approach allows the parties an opportunity to reach a settlement on costs in light of the judgment, failing which the Court will determine the quantum and basis of the costs award. The outcome serves as a total victory for the Investors, who successfully defended the Award against a sophisticated challenge to its procedural integrity.

Why Does This Case Matter?

This case is a significant addition to the jurisprudence on the setting aside of arbitral awards in Singapore. It provides a clear illustration of the "harmless error" doctrine in the context of natural justice. The judgment clarifies that even where a tribunal is found to have "missed" an entire defense—a finding that is relatively rare in Singapore's curial history—the award will still be upheld if the defense was fundamentally meritless. This prevents the set-aside process from being used as a tactical tool to delay enforcement where the underlying procedural error had no impact on the substantive justice of the case.

For practitioners, the case highlights the paramount importance of "No Waiver" clauses in commercial contracts. The Court's reliance on Clause 29.5 of the SASHA to find a lack of prejudice demonstrates that well-drafted boilerplate provisions can be the ultimate shield against claims of waiver or estoppel, even in the face of years of inaction. It also reinforces the standard of "clear and virtually inescapable inference" required to prove a failure to consider an issue, setting a high bar for claimants to overcome.

Furthermore, the decision clarifies the limits of a tribunal's duty to address every argument. By distinguishing between the Waiver Defence (which was missed) and the Buy-back Defence (which was considered but not detailed), the Court provides a roadmap for determining when a tribunal's silence is a breach of natural justice versus a legitimate exercise of its discretion to focus on essential issues. This distinction is crucial for maintaining the efficiency of the arbitral process and preventing awards from becoming overly verbose and defensive.

Finally, the case places Singapore firmly in the camp of jurisdictions that prioritize the finality of awards over technical procedural perfection. By conducting a de novo review of the merit of the missed defense to determine prejudice, the Court showed that it is willing to engage with the substance of the dispute to ensure that the high threshold for setting aside is maintained. This approach provides certainty to international commercial parties that their awards will be robustly defended in the Singapore courts.

Practice Pointers

Drafting "No Waiver" Clauses: Ensure that "No Waiver" clauses are broad and explicitly cover both failure to exercise a right and delay in doing so. As seen in this case, such clauses can be dispositive in defeating waiver-based challenges to an award.
Structuring Arbitral Pleadings: Clearly identify and label "confession and avoidance" defenses. If a defense is independent of the primary claim, it should be highlighted to ensure the tribunal does not overlook it when structuring the award's findings.
The "Inescapable Inference" Test: When challenging an award, practitioners must demonstrate that the tribunal’s failure to consider an issue is not just a possibility, but an "inescapable inference" from the award’s structure and content.
The Prejudice Filter: Before initiating a set-aside application, conduct a rigorous assessment of whether the alleged breach actually affected the outcome. A "technical" breach with no impact on the result will not lead to an award being set aside in Singapore.
Tribunal's Duty of Detail: While a tribunal must consider all essential issues, it is not required to address every sub-argument or statutory citation. Practitioners should focus on the "essential issues" rather than complaining about the omission of minor points.
De Novo Review for Prejudice: Be prepared for the court to conduct a de novo review of the merits of a "missed" defense. The court will effectively step into the shoes of the tribunal to see if the defense had any reasonable prospect of success.

Subsequent Treatment

As a decision delivered in February 2025, the subsequent treatment of this case in later judgments is not yet recorded in the extracted metadata. However, the ratio of the case—that an arbitral award will not be set aside for a failure to apply the mind to an essential issue unless such failure is a clear and virtually inescapable inference, and that such a breach must cause actual prejudice—aligns with and reinforces the established line of authority from AKN and ASG. It is expected to be cited in future set-aside applications where the "prejudice" requirement is the central point of contention.